<unk>  <unk>  is a form of adoptive immunotherapy used after hematopoietic stem cell transplantation.<unk> s from the original stem cell<unk>  are infused, after the transplant, to augment an anti-tumor immune response or ensure that the<unk>  stem cells remain engrafted. Complications of<unk>  include acute and chronic graft-versus-host disease and bone marrow aplasia, resulting in immunosuppression and susceptibility to opportunistic infections.
Donor lymphocyte infusion
Stem cell transplantation
Follicular unit transplantation
Hematopoietic stem cell transplantation
R-EPOCH regimen
DA-EPOCH regimen
DA-R-EPOCH regimen
Organ donation